Insulin pork
Also known as: Animal insulin, Hypurin Porcine, Iletin II, Insulin (pork), Pig insulin, Porcine insulin, Pork Regular Insulin
Source Insulin pork at Peptiology
Save 10% with code PEPTI-BOSSRABBIT-10
Affiliate link: we earn a commission on purchases made through this link, at no extra cost to you.
Tapping Shop Now & Save 10% copies your 10% off code PEPTI-BOSSRABBIT-10 to your clipboard. Paste it at the Peptiology checkout to claim the discount.
Summary
Porcine insulin (often called pork regular insulin) is a naturally derived insulin analogue used as a prescription hormone to control blood glucose in diabetes mellitus. It is administered by injection (subcutaneous, intramuscular, or intravenous) and functions by lowering plasma glucose, similar to human insulin.
Mechanism of Action
Porcine insulin binds to the insulin receptor on target cells, initiating the receptor's intrinsic tyrosine‑kinase activity and downstream signaling that promotes glucose uptake and suppresses hepatic glucose production. The glucose‑depressing activity observed in animal studies reflects this receptor‑mediated mechanism.
What the Research Shows
Early clinical observations documented severe allergic reactions to porcine insulin, especially when present as a contaminant in glucagon preparations. Comparative studies in rats showed that pork insulin depresses plasma glucose with a specific activity of about 25 U/mg, slightly lower than human pancreatic insulin (32 U/mg) and recombinant human insulin (27 U/mg). Metabolic clearance rates of iodinated pork insulin were similar to semisynthetic insulin, indicating comparable pharmacokinetics. In vitro work revealed that insulin (including porcine) can transiently protect tumor cells from antibody‑complement killing, an effect dependent on temperature, concentration, and exposure time. Biophysical analyses described the hydration properties of pork insulin, while enzymatic assays demonstrated that various insulin analogues competitively inhibit glutathione‑insulin transhydrogenase, with less active conformations showing higher inhibition potency. Modified porcine proinsulin and A1‑B29 derivatives exhibited slower metabolism and altered in‑vivo potency relative to in‑vitro assays.
Reported Benefits
Animal‑derived insulin provides effective glucose‑lowering activity, as shown by its ability to depress plasma glucose in rats at doses comparable to human insulin. Its pharmacokinetic profile (clearance rates) is similar to other insulin preparations, supporting its use for rapid glycemic control via injection. Historically, it has been an approved prescription option for diabetes management.
Limitations of the Evidence
Immunogenicity is a notable concern; allergic reactions to porcine insulin have been reported, especially when present as a contaminant in other drug preparations. The protective effect on tumor cells against complement‑mediated killing, observed in vitro, raises theoretical safety questions, though clinical relevance is unclear. Most modern comparative data are limited to animal models; contemporary human studies are scarce.
Safety Considerations
Porcine insulin can trigger hypersensitivity reactions, ranging from localized skin responses to severe generalized allergy, as documented in patients with insulin allergy. Contamination of other injectable drugs (e.g., glucagon) with porcine insulin may exacerbate reactions. While its clearance and potency are comparable to human insulin, clinicians should monitor for immunogenicity and adjust therapy if allergic responses occur.
How It Is Administered
Porcine insulin is supplied for injectable use and may be given subcutaneously, intramuscularly, or intravenously. Formulations are typically supplied as sterile solutions or suspensions for single‑use vials or prefilled syringes, consistent with standard insulin delivery methods.
Routes of Administration
Goals & Uses
- Hyperkalemia managementElectrolyte ManagementModerate
- Diabetic ketoacidosis (DKA) managementAcute Metabolic EmergencyModerate
- Glycemic control in type 2 diabetesMetabolicHigh
- Glycemic control in type 1 diabetesMetabolic / EndocrineHigh
- Glycemic control in type 1 diabetes mellitusEndocrine / MetabolicHigh
- Glycemic control in type 2 diabetes mellitusEndocrine / MetabolicHigh
Contraindications
- Religious or cultural restriction to porcine productsCultural/ethicalModerate
- Known hypersensitivity to porcine insulin or excipientsImmunologicHigh
- Insulin allergyImmunologicModerate
- HypoglycemiaMetabolicHigh
Adverse Effects
- HypokalemiaElectrolyteUncommon
- HypoglycemiaMetabolicCommonAbnormally low blood glucose
- Injection site reactions (lipodystrophy, lipoatrophy, lipohypertrophy)Dermatologic/localCommon
- Weight gainMetabolicCommonIncrease in body weight
- Allergic reactions (local or systemic)ImmunologicUncommon
- Injection site lipodystrophyLocalUncommon
- Insulin antibody formationImmunologicCommon
Drug Interactions
- Oral antidiabetic agents (sulfonylureas)Moderate
- Oral hypoglycemics (e.g., sulfonylureas)High
- Beta‑blockersModerate
- Beta-blockersModerate
- AlcoholModerate
- CorticosteroidsModerate
- MAO inhibitorsModerate
- Thiazide diureticsLow
Population Constraints
- PregnancyReproductive SafetyRelative
- Hepatic impairmentOrgan FunctionRelative
- Renal impairmentOrgan ImpairmentRelative
- Pediatric patientsAgeRelative
- Children <2 yearsAgeRelative
- Elderly patientsAgeRelative
- Pregnant womenReproductiveRelative
Regulatory Status
- European UnionUnapprovedNot marketed; recombinant insulin preferred.
- United StatesWithdrawnNo FDA‑approved porcine insulin product; replaced by recombinant human insulin.
- United KingdomUnapprovedSame as EU.
No longer marketed in the United States; withdrawn from FDA approval in favor of recombinant human insulin. May be available in limited markets for patients with specific insulin allergies.
Evidence & Sources
- Journal ArticleLowKitabchi AE, et al.1975-01-01T00:00:00.000000Z
- Journal ArticleLowSchlager SI, Ohanian SH, Borsos T1976-01-01T00:00:00.000000Z
- Journal ArticleLowHalban PA, et al.1981-01-01T00:00:00.000000Z
- Journal ArticleLowKhurgin IuI, Sherman FB, Tusukaliev U1977-01-01T00:00:00.000000Z
- Journal ArticleLowJones RH, et al.1976-01-01T00:00:00.000000Z
- Journal ArticleLowVarandani PT, Nafz MA, Chandler ML1975-01-01T00:00:00.000000Z
Frequently Asked Questions
Is pork insulin still used clinically today?
Porcine insulin is an approved prescription product, but its use has declined in many regions in favor of recombinant human insulin and analogues. It remains available where regulatory agencies have retained its approval.
Can porcine insulin cause allergic reactions?
Yes. Clinical reports describe severe generalized allergic responses to porcine insulin, especially when it contaminates other injectable medications. Patients with known insulin allergy should be evaluated before using pork insulin.
How does the glucose‑lowering potency of pork insulin compare to human insulin?
Animal studies showed pork insulin’s specific activity (≈25 U/mg) is slightly lower than that of human pancreatic insulin (≈32 U/mg) and recombinant human insulin (≈27 U/mg), but it still effectively lowers plasma glucose at therapeutic doses.
Does porcine insulin affect cancer cells?
In vitro experiments demonstrated that insulin, including porcine insulin, can transiently protect certain tumor cells from antibody‑complement killing. The clinical significance of this finding has not been established.
What routes can pork insulin be administered by?
It can be injected subcutaneously, intramuscularly, or intravenously, using standard sterile insulin formulations.
What is Insulin pork?
Porcine insulin (often called pork regular insulin) is a naturally derived insulin analogue used as a prescription hormone to control blood glucose in diabetes mellitus. It is administered by injection (subcutaneous, intramuscular, or intravenous) and functions by lowering plasma glucose, similar to human insulin.
What is Insulin pork used for?
Insulin pork is educationally associated with: Hyperkalemia management, Diabetic ketoacidosis (DKA) management, Glycemic control in type 2 diabetes, Glycemic control in type 1 diabetes, Glycemic control in type 1 diabetes mellitus, Glycemic control in type 2 diabetes mellitus. Educational only — not medical advice.
How is Insulin pork administered?
Recorded routes of administration: Intramuscular, Intravenous, Subcutaneous.
What are the potential side effects of Insulin pork?
Reported adverse effects include: Hypokalemia, Hypoglycemia, Injection site reactions (lipodystrophy, lipoatrophy, lipohypertrophy), Weight gain, Allergic reactions (local or systemic), Injection site lipodystrophy, Insulin antibody formation. This list is not exhaustive — consult a qualified clinician.
Who should avoid Insulin pork?
Recorded contraindications: Religious or cultural restriction to porcine products, Known hypersensitivity to porcine insulin or excipients, Insulin allergy, Hypoglycemia. Consult a qualified clinician before use.